agilon health (NYSE:AGL – Get Rating) had its target price upped by SVB Leerink from $25.00 to $33.00 in a research note issued to investors on Thursday, MarketBeat reports. SVB Leerink currently has an outperform rating on the stock. Other equities research analysts also recently issued research reports about the stock. Zacks Investment Research upgraded […]